Allarity Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Allarity Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Allarity Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -644 %, a 129% decline year-over-year.
  • Allarity Therapeutics, Inc. annual Return On Equity for 2023 was 478 %.
  • Allarity Therapeutics, Inc. annual Return On Equity for 2022 was -267 %, a 151% decline from 2021.
  • Allarity Therapeutics, Inc. annual Return On Equity for 2021 was -106 %, a 260% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -644 -2.83K -129% Apr 1, 2024 Jun 30, 2024
Q1 2024 372 +1.43K Jan 1, 2024 Mar 31, 2024
Q4 2023 478 +745 Oct 1, 2023 Dec 31, 2023
Q3 2023 712 +996 Jul 1, 2023 Sep 30, 2023
Q2 2023 2.18K +2.33K Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.05K -937 -804% Jan 1, 2023 Mar 31, 2023
Q4 2022 -267 -161 -151% Oct 1, 2022 Dec 31, 2022
Q3 2022 -284 Jul 1, 2022 Sep 30, 2022
Q2 2022 -149 Apr 1, 2022 Jun 30, 2022
Q1 2022 -117 Jan 1, 2022 Mar 31, 2022
Q4 2021 -106 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.